Search
for
Sort by
Research 31–60 of 1000+
- Telogen Effluvium Following Coronavirus Disease-2019 Infection: A Retrospective Study of 113 Cases
- Effects of the RV3466F lotion on female telogen effluvium: Results from a 16 week, multi-centric, controlled, randomized trial
- Proposing a Simpler Classification of Telogen Effluvium
- Poster 148 Severe Hair Loss during Inpatient Rehabilitation due to Telogen Effluvium: A Case Report
- Scalp capillarectasia as a trichoscopic sign of COVID‐19‐associated telogen effluvium
- SARS in Children
- Hair loss in the elderly
- Telogen effluvium: acute and chronic
- Efficacy of a wheat polar lipid complex in reducing hair loss and improving hair growth in healthy women: A randomized, double‐blind, placebo‐controlled clinical study
- Telogen Effluvium, Diagnosis and Management: A Narrative Review
- Alopecia Areata Incognita
- Telogen effluvium
- Telogen effluvium
- EFFECT OF POTASSIUM ON BLOOD-SUGAR AND PLASMA-INSULIN LEVELS IN PATIENTS UNDERGOING PERITONEAL DIALYSIS AND HÆMODIALYSIS
- Alopecia areata incognita: a comment
- Telogen Effluvium
- Chronic telogen effluvium is due to a reduction in the variance of anagen duration
- Approach to the adult female patient with diffuse nonscarring alopecia
- Telogen Effluvium
- Alopecia Associated with Gabapentin in the Treatment of Neuropathic Pain
- Clinico-Epidemiological Aspects of Telogen Effluvium In Iraqi Women
- Clinico-Epidemiological Aspects of Telogen Effluvium In Iraqi Women
- TELOGEN EFFLUVIUM: A LATE COMPLICATION OF INFLUENZA A Sw H1N1 PNEUMONIA
- An Ode to Telogen Effluvium
- A comment regarding ‘follicular Swiss cheese’ in the diagnosis of alopecia areata
- Alopecia areata incognito misdiagnosed as androgenetic alopecia- A Case Report
- 0433 JAK inhibitor halts the progression of acute exacerbation of alopecia areata
- Recurrent episodes of hair loss in a 37 year old woman
- 0527 Effectiveness of janus kinase inhibitor for rapidly progressive acute alopecia areata
- Characteristics of hair loss in COVID-19 patients in Thailand.